SlideShare une entreprise Scribd logo
1  sur  28
Télécharger pour lire hors ligne
Using Targeted Resequencing Microarrays for
     Simultaneous Definitive Detection and Identification of
               Multiple Respiratory Pathogens.



                          Agnieszka M. Lichanska, Clark Tibbetts, and
                                     Matthew C. Lorence
                                   TessArae, LLC, Potomac Falls, Virginia, USA




TessArae, LLC, Proprietary Information
Overview

               Re-sequencing technology vs. traditional diagnostic
                techniques
                   How does re-sequencing work?
                   How are the techniques different?
               Identification of new pathogens - an example: novel
                H1N1 flu
               Additional examples of use of RPM-Flu 3.1 assay
               Summary



TessArae, LLC, Proprietary Information
Shift in Microbial Diagnostics


                                                                                                 TessArae Inc.
                                                                                              TessArray RPM-Flu v3.1
                                                                                               Respiratory Pathogen
                                                                                                      Panel
                                                                                                  P/N: 520-191




                                                                                             TessArray™




Phenotypic detection                                            Genotypic detection
 and identification                                              and identification


                                Mainly single result per test             Multiple results per one test
                                                                        Multiple signatures per pathogen
                                                                          Detection and confirmation

  TessArae, LLC, Proprietary Information
RPM Strategy
                      GTATGGTAGTTGAGATAATTAGCTT
                                                                      Probes to interrogate
                      GTATGGTAGTTGCGATAATTAGCTT                       center position of first
                                                                      complementary target
                      GTATGGTAGTTGGGATAATTAGCTT                       strand

                      GTATGGTAGTTGTGATAATTAGCTT
   Target             GTATGGTAGTTGGGATAATTAGCTTGATGT
                      CATACCATCAACCCTATTAATCGAACTACA
                      CATACCATCAACACTATTAATCGAA
                                                                      Probes to interrogate
                      CATACCATCAACCCTATTAATCGAA                       center position of second
                                                                      complementary target
                      CATACCATCAACGCTATTAATCGAA                       strand

                      CATACCATCAACTCTATTAATCGAA
                                 25-base window of 8 transducers
                          Hemagglutinin A/Goose/Guangdong/1/96/H5N1
TessArae, LLC, Proprietary Information
RPM Strategy
                   GTATGGTAGTTGGAATAATTAGCTTG
                   GTATGGTAGTTGGCATAATTAGCTTG
                   GTATGGTAGTTGGGATAATTAGCTTG
                   GTATGGTAGTTGGTATAATTAGCTTG
                   GTATGGTAGTTGGGATAATTAGCTTGATGT
                   CATACCATCAACCCTATTAATCGAACTACA
                   CATACCATCAACCATATTAATCGAAC
                   CATACCATCAACCCTATTAATCGAAC
                   CATACCATCAACCGTATTAATCGAAC
                   CATACCATCAACCTTATTAATCGAAC
                             Hemagglutinin A/Goose/Guangdong/1/96/H5N1

TessArae, LLC, Proprietary Information
RPM Strategy
                  GTATGGTAGTTGGGATAATTAGCTTGA
                  GTATGGTAGTTGGGCTAATTAGCTTGA
                  GTATGGTAGTTGGGGTAATTAGCTTGA
                  GTATGGTAGTTGGGTTAATTAGCTTGA
                  GTATGGTAGTTGGGATAATTAGCTTGATGT
                  CATACCATCAACCCTATTAATCGAACTACA
                  CATACCATCAACCCAATTAATCGAACT
                  CATACCATCAACCCCATTAATCGAACT
                  CATACCATCAACCCGATTAATCGAACT
                  CATACCATCAACCCTATTAATCGAACT
                             Hemagglutinin A/Goose/Guangdong/1/96/H5N1


TessArae, LLC, Proprietary Information
Influenza A HA1    Coronavirus (229E)
                                                                      Influenza A HA2    Coronavirus (OC43)
                                                                      Influenza A HA3    Coronavirus (NL63)
                                                                      Influenza A HA4    Coronavirus (SARS Urbani)

       TessArray®                                                     Influenza A HA5
                                                                      Influenza A HA6
                                                                                         Cytomegalovirus (HHV-5)
                                                                                         Enteroviruses:
                                                                      Influenza A HA7    • Coxsackievirus (5 types)
       RPM-Flu 3.1                                                    Influenza A HA8
                                                                      Influenza A HA9
                                                                                         • Echovirus (8 types)
                                                                                         • Rhinovirus (27 types)
                                             TessArae, LLC            Influenza A HA10   Measles Virus
                                          TessArray RPM-Flu v3.1
                                         Respiratory Pathogen Panel   Influenza A HA11   Metapneumovirus (types A, B)
                                                P/N: 520-191
                                                                      Influenza A HA12   Parainfluenza 1
                                                                      Influenza A HA13   Parainfluenza 2
                                                                      Influenza A HA14   Parainfluenza 3
                                                                      Influenza A HA15   Parainfluenza 4a
                                                                      Influenza A HA16   Parainfluenza 4b
                                                                                         RSV A
                                                                      Influenza A NA1    RSV B
                                                                      Influenza A NA2    Rubella Virus
                                         TessArray™                   Influenza A NA3
                                                                      Influenza A NA4    Bordatella pertussis
                                                                      Influenza A NA5    Corynebacterium diphtheriae
                                                                      Influenza A NA6    Chlamydia psittaci
Simultaneous differential diagnosis                                   Influenza A NA7    Chlamydia trachomatis
                                                                      Influenza A NA8    Chlamydophila pneumoniae
of influenza-like illness                                             Influenza A NA9    Haemophilus influenzae
                                                                      Influenza A Mtx    Klebsiella pneumoniae
30 different types of viral and                                       Influenza A NS     Legionella pneumophila
                                                                      Influenza A PB2    Moraxella catarrhalis
bacterial respiratory pathogens                                       Influenza B HA1    Mycobacterium kansasii
                                                                      Influenza B HA2    Mycobacterium tuberculosis
938,032 oligonucleotide probes                                        Influenza B NA1    Mycoplasma pneumoniae
                                                                                         Neisseria meningitidis
                                                                      Influenza B Mtx    Pseudomonas aeruginosa
117,254 nucleotides of targeted                                                          Staphylococcus aureus
                                                                      Adenovirus B       Streptococcus agalactiae
pathogen gene sequences per assay                                     Adenovirus C       Streptococcus pneumoniae
                                                                      Adenovirus D       Streptococcus pyogenes
                                                                      Adenovirus E
                                                                                         Variola major
                                                                                         Bacillus anthracis
                                                                                         Francisella tularensis
                                                                                         Yersinia pestis

TessArae, LLC, Proprietary Information
How the RPM Assay Works?


     Control Template Live Influenza Vaccine (FluMist® 2004-2005)

      Trivalent mixture of different influenza virus A/HN and B subtypes
              A/Canterbury/20/1999 (H1N1)
              A/Wyoming/3/2003 (H3N2)
              B/Jilin/20/2003
              Hemagglutinin and Neuraminidase Genes from these Vaccine Strains


     Engineered by Reassortment with Cold-Adapted Master Strains
           A/Ann Arbor/6/1960 (H2N2)
           B/Ann Arbor/1/1966
           Matrix and Other Viral Genes from Master Strains



TessArae, LLC, Proprietary Information
Background
                                                 Chip




                                                                                    Segment




           Translation Key:


Tile      T C
          GA
                T   G    C    A




TGGAAAATGAAAGGACTTTGGATTTCCATGACTCCAATGTGAAGA
                                  Influenza A Virus segment 4 hemagglutinin (HA1)
 TessArae, LLC, Proprietary Information
>EV70UTR:NRL_KB_FluVaccine_082206 Start=12 End=707
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnncnannnnnngnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnannnnnnnnnnnnnnnnnnnnnnnnnnnnnnnng
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnntnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnncnnngnnnnnnnnnnnnn    Enterovirus 70 UTR
    nnnnnnnnnnnnnnnnnnnnnnnnngnnnnntnnnnnnnnnnnnnnnncncnnnnnnnnnncnnnnnnnnnnnnnnnnnt
    nnnnnnnnnnntnngancnnnnngnnnnnnnnnnccnnnngnnnnnnnnnnnnnnnnnnggnnnnnnnnnnnncnnnnnn         Negative
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnacnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnn
    >FLUAHA1:NRL_KB_FluVaccine_082206 Start=12 End=1487
    agaagaatgtgacagngncncactctgtcaacctacttgaggacagtcacaatggaaaactatgtctactaaaaggaata
    gccccncnnnnnntgggtaattgcagcgttgccggatggatcttaggaaacccagaatgcgaattactgatttccaagga
    atcatggtcctacattgtagaaacaccaaatcctgagaatggaacatgttacccagggtatttcgccgactatgaggaac
    tgagggagcaattgagttcagtatcttcatttgagagattcgaaatattccccaaagaaagctcatggcccaaccacacc
    gtaaccggagtatcagcatcatgcncccnnnnngggaaaagcagtttttacagaaatttgctatggcngncnnnnnngaa
    tggnnnnnnnccaaacctgagcaagtcctatgtaaacaacaaagagaaagaagtccttgtactatgggcnntncntcacc
    cgcctaacanagggaaccaaagggccctctatcatacagaaaatgcttatgtctctgtagtgtcttcacattatagcaga
    agattcaccccagaaatagccaaaagacccaaagtaagagatcaggaaggaagaatcaactactactggactctgcngga
    acctggggatacaataatatttgaggcaaatggaaatctaatagcgccatggtatgcttttgcactgagtagaggctttg    Type A Flu - HA1
    gatcaggaatcatcacctcaaatgcaccaatggatgaatgtgatgcgaagtgtcaaacacctcagggagctataaacagc        Positive
    agtcttcctttccagaatgtacacccagtcacaataggagagtgtccaaagtatgtcaggagtgcaaaatnaaggatggn
    tacaggactaaggaacatcccntccattcaatccagaggtttgtttggagccattgccggtttcattgaagnnnngtgga
    ctggaatggtagatgggtggtatggttatcatcatcagaatgagcaaggatcnggnnnnnnnncagatcaaaaaagtnca
    caaaatgccattaacgggattacaaacaaggtgannnnnnnnnnnnagaaaatgaacactcaattcacngcngtgggcaa
    agaattcaacaaattggaaagaaggatggaaaacttaaataaaaaagttgatgatgggtttctagacatttggannnnnn
    nnncagaattgttggttctacTGGAAAATGAAAGGACTTTGGATTTCCATGACTCCAATGTGAAGAatctgtatgagaaa
    gtaaaaagccaattaaagaataatgccaaagaaataggaaacgggtgttttgaattctatcacaagtgtaacaatgaatg
    catggagagtgtgaaaaatggaacttatgactatccaaaatattccgaagaatcaaagttaaacagggagaaaattgatg
    gagtgaaattggaatcaatgggagtctatcagattc
    >FLUAHA10:NRL_KB_FluVaccine_082206 Start=12 End=787
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnngnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnngnnnnncnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnnnnnnntnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn   Type A Flu - HA10
    nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnnnnnnnnnnnnnnnnnannnnnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnnn       Negative
    nnnnnnnnnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nnnnnnncaggaangagnannnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
    nggnnnnnntnnnangnaggnnggnngnnnnnnnnnnnnnnnnnnncnnnnnnnnn…

TessArae, LLC, Proprietary Information
How to Identify a Novel Pathogen?




TessArae, LLC, Proprietary Information
RPM Detection of Novel Strains

                     Old Strain                                  New Strain

    TGGTAGTTGGGAAAATTAGCTTGAT              Forward         TGGTAGTTGGGAAAATTAGCTTGAT
    TGGTAGTTGGGACAATTAGCTTGAT              strand          TGGTAGTTGGGACAATTAGCTTGAT
                                           sequence
    TGGTAGTTGGGAGAATTAGCTTGAT                              TGGTAGTTGGGAGAATTAGCTTGAT
                                           variant
    TGGTAGTTGGGATAATTAGCTTGAT              detection       TGGTAGTTGGGATAATTAGCTTGAT

CATACCATCAACCCTATTAATCGAACTACAGC            target      CATACCATCAACCCTGTTAATCGAACTACAGC
GTATGGTAGTTGGGATAATTAGCTTGATGTCG                        GTATGGTAGTTGGGACAATTAGCTTGATGTCG
    ACCATCAACCCTATTAATCGAACTA               Reverse        ACCATCAACCCTATTAATCGAACTA
    ACCATCAACCCTCTTAATCGAACTA               strand         ACCATCAACCCTCTTAATCGAACTA
    ACCATCAACCCTGTTAATCGAACTA               sequence       ACCATCAACCCTGTTAATCGAACTA
    ACCATCAACCCTTTTAATCGAACTA               variant        ACCATCAACCCTTTTAATCGAACTA
                                            detection




  TessArae, LLC, Proprietary Information
Detection of Novel Strains




TessArae, LLC, Proprietary Information
Novel H1N1 Influenza Detection




TessArae, LLC, Proprietary Information
Detecting Seasonal Strains of Influenza



                RPM-Detector Tiles for Seasonal A/H1N1 and Seasonal A/H3N2 Influenza Viruse s
            Vir u s      Target Gen e         Detector Tile Sequence/Strai n   Leng t h  Prob e s
           A/H1 N 1 Hemagglutinin(A/HA1 )    A/New Caledonia/20/1999(H1N1) 1500 bp        12,000
           A/H1 N 1 Neuraminidase(A/N A 1 ) A/New Caledonia/20/1999(H1N1) 1200 bp         9,600
           A/H1 N 1   Matrix(A/H1N1-M )       A/Canterbury/100/2000(H1N1)      850 bp     6,800

           A/H3 N 2         Hemagglutinin(A/HA3 )     A/Canterbury /125/2005(H3 N 2 )   1500 bp   12,000
           A/H3 N 2         Neuraminidase(A/N A 2 )   A/Canterbury /125/2005(H3 N 2 )   1200 bp   9,600
           A/H3 N 2           Matrix(A/H3N2-M )       A/Canterbury /125/2005(H3 N 2 )    850 bp   6,800




TessArae, LLC, Proprietary Information
A Sentinel Case

                          April 2009:
                                    Patient presents at Washington, DC hospital
                                    Recently returned from vacation in Mexico
                                    Convalescing from recent flu-like illness
                                    Anxious about reports of novel influenza outbreak


                                                   TessArray Outcomes:

            01 May 2009 - Best Matches
            L20309, X90504 H influenzae outer membrane protein P5
            A/duck/Guanxi/2004(H5N1); A/chicken/Yogjakarta/2004(H5N1)


            Very unusual result suggested patient had been infected by an avian influenza virus
            Database updated following week, new sequence records from Mexico outbreak isolates


            05 May 2009 - Best Matches
            L20309, X90504 H influenzae outer membrane protein P5
            A/California/07/2009(H1N1); A/Texas/04/2009(H1N1)



               Perfect Match to New CDC Strain!
               From a Test Designed in 2006 With No Prior Knowledge of New Strain


TessArae, LLC, Proprietary Information
T S R A - A ML_CNMC_01_050109 (“RPM-Flu Sentinel Case”)
                                                          Best Matches from VSRD Archive               Best Matches from VSRD Archive
                                                               Updated November 2008                          Updated May 2009

                                                            A/chicken/Indonesia/7/2003(H5N1)
                                                           A/chicken/Puebla/231-5284/98(H5N2)          A/chicken/Puebla/231-5284/98 (H5N2)
                                                       A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)
                                                            A/duck/Guangxi/1436/2006(H5N1)
                                                             A/duck/Guangxi/351/2004(H5N1)
                                                            A/duck/Guangxi/3548/2005(H5N1)
                                                             A/duck/Guangxi/380/2004(H5N1)
                                                            A/duck/Guangxi/4016/2005(H5N1)
                                                       A/hooded vulture/Burkina Faso/2/2006(H5N1)
                                                             A/mallard/Alberta/111/99(H4N6)             A/mallard/Alberta/111/99(H4N6)
                                                          A/mallard/Maryland/1235/2006(H3N6)          A/mallard/Maryland/1235/2006(H3N6)
                                                         A/quail/Tasikmalaya/BPPV4/2004(H5N1)
                                                            A/swine/Hong Kong/1197/02(H3N2)             A/swine/Hong Kong/1197/02(H3N2)
                                                                                                           A/swine/Iowa/930/01(H1N2)
                                                            A/swine/Virginia/670/1987(H1N1)
                                                            A/swine/Virginia/671/1987(H1N1)
                                                                                                    A/swine/British Columbia/28103/2005(H3N2)

                                                                                                           A/California/04/2009(H1N1)
                                                                                                           A/California/05/2009(H1N1)
                                                                                                           A/California/06/2009(H1N1)
                                                                                                           A/California/07/2009(H1N1)

RPM detection and identification works for                                                                 A/California/08/2009(H1N1)
                                                                                                           A/California/09/2009(H1N1)
                                                                                                           A/California/10/2009(H1N1)
strains and variants                                                                                       A/California/14/2009(H1N1)
                                                                                                        A/Canada-ON/RV1527/2009(H1N1)

that share at least 80% sequence similarity to                                                             A/New York/06/2009(H1N1)
                                                                                                           A/New York/10/2009(H1N1)

array detector tiles
                                                                                                           A/New York/11/2009(H1N1)
                                                                                                           A/New York/15/2009(H1N1)
                                                                                                           A/New York/18/2009(H1N1)
                                                                                                           A/New York/19/2009(H1N1)
                                                                                                           A/New York/20/2009(H1N1)
                                                                                                           A/New York/22/2009(H1N1)
                                                                                                             A/Ohio/07/2009(H1N1)
                                                                                                             A/Texas/04/2009(H1N1)
                                                                                                             A/Texas/05/2009(H1N1)


190/215 = 88%




     The RPM-Flu 3.1 designed for A/H5N1 in 2006 is capable to sensitively detect and differentiate
  the Novel A/H1N1 SOIV from Seasonal A/H1N1 and Seasonal A/H3N2 subtypes without modification
   TessArae, LLC, Proprietary Information
Avian A/H5N1 matrix
    gene resequencing
    detector tile sequence
    (top sequence)

    2009 Novel H1N1
    (A/Pensacola/INS107/200
    9(H1N1)) strain (middle
    sequence)


    Sequence from a high titer
    stock of a 2009 Novel H1N1
    outbreak strain strain,
    A/NHRC-
    California/BRD_40116(H1N1)
    (bottom sequence)

               Legend:
               “x” = Mismatch
               “|” = Match
TessArae, LLC, Proprietary Information
Analytical Sensitivity with Cultured Influenza Virus




         Seasonal H1N1                        Seasonal H3N2            Novel H1N1

LoD (95%) TCID50/ml

TessArray RPM-Flu                          CDC rRT-PCR (JBAIDS)
 Novel A/H1N1                    1,740     Novel A/H1N1      5,000
 Seasonal A/H1N1                   102     Seasonal A/H1N1      10
 Seasonal A/H3N2                   224     Seasonal A/H3N2     100


  TessArae, LLC, Proprietary Information
Analytical Sensitivity
                                            Cultured Influenza Virus
                                                       Seasonal       Seasonal       2009 Novel
                                     Controls
                                                        A/H1N1         A/H3N2       A/H1N1 SOIV
                   Endpoint LoD Titration
                       Seasonal A/H1N1                38/38 (100%)    0/41 (0%)      0/41 (0%)
                       Seasonal A/H3N2                 0/58 (0%)     44/44 (100%)    0/58 (0%)
                       2009 Novel A/H1N1(SOIV)         0/55 (0%)      0/55 (0%)     44/44 (100%)


                   Positive Clinical Specimens
                       Seasonal A/H1N1                13/13 (100%)    0/13 (0%)      0/13 (0%)
                       Seasonal A/H3N2                 0/31 (0%)     31/31 (100%)    0/31 (0%)
                       2009 Novel A/H1N1(SOIV)          0/8 (0%)       0/8 (0%)      8/8 (100%)


                   Negative Controls
                       Avian A/H5N1-positive           0/16 (0%)      0/16 (0%)      0/16 (0%)
                       Other High Load Pathogens       0/24 (0%)      0/24 (0%)      0/24 (0%)
                       Water Blanks                    0/14 (0%)      0/14 (0%)      0/14 (0%)
                       Clinical Negative by PCR        0/501 (0%)     0/501 (0%)     0/501 (0%)




TessArae, LLC, Proprietary Information
Detecting Emergent Strains
                What’s on the Device:                        2004-5 FluMist
               A/New Caledonia/20/1999(H1N1) Hemagglutinin   A/New Caledonia/20/1999(H1N1)
               A/New Caledonia/20/1999(H1N1) Neuraminidase   A/New Caledonia/20/1999(H1N1)
               A/Canterbury/100/2000(H1N1) Matrix            A/Ann Arbor/6/1960(H2N2)
               A/Canterbury/125/2005 (H3N2) Hemagglutinin    A/Wyoming/03/2003 (H3N2)
               A/Canterbury/125/2005 (H3N2) Neuraminidase    A/Wyoming/03/2003 (H3N2)
               A/Canterbury/125/2005 (H3N2) Matrix           A/Ann Arbor/6/1960(H2N2)

                     What it Told Us:                        2009-10 FluMist
                                                             A/South Dakota/6/2007(H1N1)
                                                             A/South Dakota/6/2007(H1N1)
                                                             A/Ann Arbor/6/1960(H2N2)
                                                             A/Uruguay/716/2007 (H3N2)
                              TessArae, LLC                  A/Uruguay/716/2007 (H3N2)
                           TessArray RPM-Flu v3.1
                          Respiratory Pathogen Panel         A/Ann Arbor/6/1960(H2N2)
                                 P/N: 520-191




                                                             2006-7 FluZone
                                                             A/New Caledonia/20/1999(H1N1)
                                                             A/New Caledonia/20/1999(H1N1)
                                                             A/Puerto Rico/8/1934(H1N1)
                                                             A/Wisconsin/67/2005 (H3N2)
                         TessArray™                          A/Wisconsin/67/2005 (H3N2)
                                                             A/Puerto Rico/8/1934(H1N1)


                                                             2009-10 FluVirin
 When Confronted With Different                              A/South Dakota/6/2007(H1N1)
 Strains the Array Still Tells Us                            A/South Dakota/6/2007(H1N1)
                                                             A/Puerto Rico/8/1934(H1N1)
 What Is Present Based on the                                A/Uruguay/716/2007 (H3N2)
                                                             A/Uruguay/716/2007 (H3N2)
 Sequences of the Organisms
                                                             A/Puerto Rico/8/1934(H1N1)

TessArae, LLC, Proprietary Information
Avian Influenza Subtypes: Differential Diagnostics
                          Specimens from USDA ARS SEPRL reference archive (20 Mar 08)
                                  Sample   RPM Assay       Match               SEPRL Reference Strain
                                     1        H1N1          H1N1                A/Turkey/Kansas/4880/80

                                     2        H2N8          H2N8                A/Herring Gull/DE/677/88

                                     3        H3N2          H3N2                A/turkey/MN/366767/2005

                                     4        H4N6          H4N6             A/Blue Winged Teal/LA/240B/88

                                     6        H7N2          H7N2                  A/quail/PA/20304/98

                                     7        H8N4          H8N4               A/turkey/CO/169118-13/02

                                     9       H10N7         H10N7                 A/quail/NJ/25254-22/95

                                     10      H11N3         H11N3                  A/chicken/NJ/4645/96

                                     11      H12N5         H12N5                   A/duck/LA/188D/87

                                     12      H13N6         H13N6                   A/gull/MD/1824/78

                                     13    AMPV, No AI   AMPV, No AI    Avian Metapneumovirus (Colorado Strain)

                                     14       H5N3          H5N3               A/duck/Singapore/F119/97

                                     15       H7N3          H7N3              A/chicken/Chile(F0)/176822/02

                                     16       No AI         No AI      Avian Paramyxovirus I (NDV, RPM-TEI assay)

                                     17       H5N2          H5N2              A/chicken/Mex/26654-1374/94

                                     18       H7N1          H7N1                  A/turkey/Italy/4580/99

                                     19       H7N3          H7N3             A/chicken/Pakistan/1369-CR2/95

                                     20       H7N7          H7N7                  A/chicken/Victoria/85

                                     21      H14N5         H14N5                 A/mallard/Gurjev/263/82

                                     22      H15N9         H15N9            A/Shearwater/W. Australia/2576/79



TessArae, LLC, Proprietary Information
Avian Influenza Subtypes: Differential Diagnostics
                       Reconciliation of Inter-Platform Results Discrepancies by
                   de novo DNA Sequencing of Viral Genes from Original Specimens

                           CDC-Certified        Ibis-T5000          HA RSLT (P1)      TessArray®              Gold Standard
       Sample ID          H5 (Asian) PCR          ESI-MS                              RPM-Flu v3.1           DNA Sequencing
      2006900845                 H5               H5N1                     H5            H5N1                   not tested
      2006906089                 H5               H5N1                     H5            H5N1                   not tested
      2006900590                 H5               H5N1                     H5            H5N1                   not tested
      2006902838                 H5               H5N1                     H5            H5N1                   not tested
      2006902764             not tested           H5N1                     H5            H5N1                      H5N1
      2006905588                 Flu           UNKNOWN                     H7            H7N7                      H7N7
      2004909864             not tested           H9N2               UNKNOWN             H7N7                       H7
      2005912823                 Flu              H7N7               UNKNOWN             H10N7                    H10N7
      2005912908             not tested           H7N7                     H10           H10N7                    H10N7
      2004900600                 Flu              H7N7                     H10           H10N7                    H10N7
      2004900845                 H5               H5N1                     H10      H10N7 or H10N5                H10N7
      2004900688             not tested           H7N7                     H11           H11N?                     H11
      2005912306                 Flu              NEW                UNKNOWN        H13N6 or H13N8                 H13


                                                                                                       Lin et al PLOS 2009

                              = Conflict with de novo sequencing results           = Results concordant with de novo sequencing

TessArae, LLC, Proprietary Information
Longitudinal Data Analysis




CT_Healthy_Control_080508
                                                         CT_Sick_Day4_080603 Metapneumovirus




CT_Sick_050509 Rhinovirus
But not the novel A/H1N1!
                                                   CT_Sick_042010 Parainfluenza Virus
  TessArae, LLC, Proprietary Information
MLST-like Epidemiological Analysis:
                                         Genomic diversity of Haemophilus influenzae from
                                         50 Different Patients at MCRD San Diego




TessArae, LLC, Proprietary Information
MLST-Like Epidemiological Analysis:
                                         Clonal genomic uniformity of Adenovirus Type 4
                                         in Same 50 Patients at MCRD San Diego




TessArae, LLC, Proprietary Information
Summary

             Real-time Epidemic/Pandemic Surveillance in Human and Animal
              Populations
             Simultaneous Detection and Definitive Identification of Multiple Pathogens
                Characterization of Difficult Cases
             Superior to Benchmark Platform Sensitivity and Specificity
                Limits of Detection ~ 102 Genome Equivalents/specimen
             Zero False Positive Detection Events
             Immediate Identification of Known and Unknown Strains and Variants
                Surveillance of Shift and Drift in Populations
                Same Day Results
             RPM Sequence-based Detector Array
                Six Sigma Data Quality
                Basecall Error Rate ≥ 10-6




TessArae, LLC, Proprietary Information
Acknowledgements
       TessArae, LLC - Potomac Falls, VA
                         Clark Tibbetts      Brian Weslowski     Leah Morris
                         Matthew Lorence     Lisa Borsuk         Klaus Schafer
       Naval Health Research Center/Naval Respiratory Disease
       Laboratory, San Diego, CA
                         David Metzgar                Chris Myers         Christian Hansen
                         CDR Kevin Russell            Jason Brown         Larivhie Dela Cruz
                         CDR Dennis Faix              Miguel Osuna        David Ortiz
      Naval Research Laboratory/Center for Bio/Molecular Science and
      Engineering - Washington, DC
                        Joel Schnur          Anthony Malanoski           Nina Long
                        David Stenger        Baochuan Lin                Carolyn Kidd
                        Zheng Wang           Dzung Thach                 Kate Blaney



TessArae, LLC, Proprietary Information

Contenu connexe

En vedette

En vedette (9)

Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicNext Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
 
Plex ID Congrès SJBM Marseille 2013
Plex ID Congrès SJBM Marseille 2013Plex ID Congrès SJBM Marseille 2013
Plex ID Congrès SJBM Marseille 2013
 
Bringing Microfluidics To Life
Bringing Microfluidics To LifeBringing Microfluidics To Life
Bringing Microfluidics To Life
 
Innovations in Medical Devices: Medtronic Advanced Energy
Innovations in Medical Devices: Medtronic Advanced EnergyInnovations in Medical Devices: Medtronic Advanced Energy
Innovations in Medical Devices: Medtronic Advanced Energy
 
CHI's Clinical Trial Oversight Summit, June 1-3, 2015, Boston, MA
CHI's Clinical Trial Oversight Summit, June 1-3, 2015, Boston, MACHI's Clinical Trial Oversight Summit, June 1-3, 2015, Boston, MA
CHI's Clinical Trial Oversight Summit, June 1-3, 2015, Boston, MA
 
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
New Molecular Approaches to Identify 21st Century Microbes - Dr Melissa Mille...
 
Info kids
Info kidsInfo kids
Info kids
 
Journée de l'innovation 2014
Journée de l'innovation 2014Journée de l'innovation 2014
Journée de l'innovation 2014
 
Diagnostic rapide: et si nous copions la nature?
Diagnostic rapide:     et si nous copions la nature?Diagnostic rapide:     et si nous copions la nature?
Diagnostic rapide: et si nous copions la nature?
 

Dernier

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 

Dernier (20)

04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Advantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your BusinessAdvantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your Business
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
HTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation StrategiesHTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation Strategies
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 

Presentation from Bioconference Live 2010

  • 1. Using Targeted Resequencing Microarrays for Simultaneous Definitive Detection and Identification of Multiple Respiratory Pathogens. Agnieszka M. Lichanska, Clark Tibbetts, and Matthew C. Lorence TessArae, LLC, Potomac Falls, Virginia, USA TessArae, LLC, Proprietary Information
  • 2. Overview  Re-sequencing technology vs. traditional diagnostic techniques  How does re-sequencing work?  How are the techniques different?  Identification of new pathogens - an example: novel H1N1 flu  Additional examples of use of RPM-Flu 3.1 assay  Summary TessArae, LLC, Proprietary Information
  • 3. Shift in Microbial Diagnostics TessArae Inc. TessArray RPM-Flu v3.1 Respiratory Pathogen Panel P/N: 520-191 TessArray™ Phenotypic detection Genotypic detection and identification and identification Mainly single result per test Multiple results per one test Multiple signatures per pathogen Detection and confirmation TessArae, LLC, Proprietary Information
  • 4. RPM Strategy GTATGGTAGTTGAGATAATTAGCTT Probes to interrogate GTATGGTAGTTGCGATAATTAGCTT center position of first complementary target GTATGGTAGTTGGGATAATTAGCTT strand GTATGGTAGTTGTGATAATTAGCTT Target GTATGGTAGTTGGGATAATTAGCTTGATGT CATACCATCAACCCTATTAATCGAACTACA CATACCATCAACACTATTAATCGAA Probes to interrogate CATACCATCAACCCTATTAATCGAA center position of second complementary target CATACCATCAACGCTATTAATCGAA strand CATACCATCAACTCTATTAATCGAA 25-base window of 8 transducers Hemagglutinin A/Goose/Guangdong/1/96/H5N1 TessArae, LLC, Proprietary Information
  • 5. RPM Strategy GTATGGTAGTTGGAATAATTAGCTTG GTATGGTAGTTGGCATAATTAGCTTG GTATGGTAGTTGGGATAATTAGCTTG GTATGGTAGTTGGTATAATTAGCTTG GTATGGTAGTTGGGATAATTAGCTTGATGT CATACCATCAACCCTATTAATCGAACTACA CATACCATCAACCATATTAATCGAAC CATACCATCAACCCTATTAATCGAAC CATACCATCAACCGTATTAATCGAAC CATACCATCAACCTTATTAATCGAAC Hemagglutinin A/Goose/Guangdong/1/96/H5N1 TessArae, LLC, Proprietary Information
  • 6. RPM Strategy GTATGGTAGTTGGGATAATTAGCTTGA GTATGGTAGTTGGGCTAATTAGCTTGA GTATGGTAGTTGGGGTAATTAGCTTGA GTATGGTAGTTGGGTTAATTAGCTTGA GTATGGTAGTTGGGATAATTAGCTTGATGT CATACCATCAACCCTATTAATCGAACTACA CATACCATCAACCCAATTAATCGAACT CATACCATCAACCCCATTAATCGAACT CATACCATCAACCCGATTAATCGAACT CATACCATCAACCCTATTAATCGAACT Hemagglutinin A/Goose/Guangdong/1/96/H5N1 TessArae, LLC, Proprietary Information
  • 7. Influenza A HA1 Coronavirus (229E) Influenza A HA2 Coronavirus (OC43) Influenza A HA3 Coronavirus (NL63) Influenza A HA4 Coronavirus (SARS Urbani) TessArray® Influenza A HA5 Influenza A HA6 Cytomegalovirus (HHV-5) Enteroviruses: Influenza A HA7 • Coxsackievirus (5 types) RPM-Flu 3.1 Influenza A HA8 Influenza A HA9 • Echovirus (8 types) • Rhinovirus (27 types) TessArae, LLC Influenza A HA10 Measles Virus TessArray RPM-Flu v3.1 Respiratory Pathogen Panel Influenza A HA11 Metapneumovirus (types A, B) P/N: 520-191 Influenza A HA12 Parainfluenza 1 Influenza A HA13 Parainfluenza 2 Influenza A HA14 Parainfluenza 3 Influenza A HA15 Parainfluenza 4a Influenza A HA16 Parainfluenza 4b RSV A Influenza A NA1 RSV B Influenza A NA2 Rubella Virus TessArray™ Influenza A NA3 Influenza A NA4 Bordatella pertussis Influenza A NA5 Corynebacterium diphtheriae Influenza A NA6 Chlamydia psittaci Simultaneous differential diagnosis Influenza A NA7 Chlamydia trachomatis Influenza A NA8 Chlamydophila pneumoniae of influenza-like illness Influenza A NA9 Haemophilus influenzae Influenza A Mtx Klebsiella pneumoniae 30 different types of viral and Influenza A NS Legionella pneumophila Influenza A PB2 Moraxella catarrhalis bacterial respiratory pathogens Influenza B HA1 Mycobacterium kansasii Influenza B HA2 Mycobacterium tuberculosis 938,032 oligonucleotide probes Influenza B NA1 Mycoplasma pneumoniae Neisseria meningitidis Influenza B Mtx Pseudomonas aeruginosa 117,254 nucleotides of targeted Staphylococcus aureus Adenovirus B Streptococcus agalactiae pathogen gene sequences per assay Adenovirus C Streptococcus pneumoniae Adenovirus D Streptococcus pyogenes Adenovirus E Variola major Bacillus anthracis Francisella tularensis Yersinia pestis TessArae, LLC, Proprietary Information
  • 8. How the RPM Assay Works?  Control Template Live Influenza Vaccine (FluMist® 2004-2005)  Trivalent mixture of different influenza virus A/HN and B subtypes  A/Canterbury/20/1999 (H1N1)  A/Wyoming/3/2003 (H3N2)  B/Jilin/20/2003  Hemagglutinin and Neuraminidase Genes from these Vaccine Strains  Engineered by Reassortment with Cold-Adapted Master Strains  A/Ann Arbor/6/1960 (H2N2)  B/Ann Arbor/1/1966  Matrix and Other Viral Genes from Master Strains TessArae, LLC, Proprietary Information
  • 9. Background Chip Segment Translation Key: Tile T C GA T G C A TGGAAAATGAAAGGACTTTGGATTTCCATGACTCCAATGTGAAGA Influenza A Virus segment 4 hemagglutinin (HA1) TessArae, LLC, Proprietary Information
  • 10. >EV70UTR:NRL_KB_FluVaccine_082206 Start=12 End=707 nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnncnannnnnngnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnannnnnnnnnnnnnnnnnnnnnnnnnnnnnnnng nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnntnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnncnnngnnnnnnnnnnnnn Enterovirus 70 UTR nnnnnnnnnnnnnnnnnnnnnnnnngnnnnntnnnnnnnnnnnnnnnncncnnnnnnnnnncnnnnnnnnnnnnnnnnnt nnnnnnnnnnntnngancnnnnngnnnnnnnnnnccnnnngnnnnnnnnnnnnnnnnnnggnnnnnnnnnnnncnnnnnn Negative nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnacnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnn >FLUAHA1:NRL_KB_FluVaccine_082206 Start=12 End=1487 agaagaatgtgacagngncncactctgtcaacctacttgaggacagtcacaatggaaaactatgtctactaaaaggaata gccccncnnnnnntgggtaattgcagcgttgccggatggatcttaggaaacccagaatgcgaattactgatttccaagga atcatggtcctacattgtagaaacaccaaatcctgagaatggaacatgttacccagggtatttcgccgactatgaggaac tgagggagcaattgagttcagtatcttcatttgagagattcgaaatattccccaaagaaagctcatggcccaaccacacc gtaaccggagtatcagcatcatgcncccnnnnngggaaaagcagtttttacagaaatttgctatggcngncnnnnnngaa tggnnnnnnnccaaacctgagcaagtcctatgtaaacaacaaagagaaagaagtccttgtactatgggcnntncntcacc cgcctaacanagggaaccaaagggccctctatcatacagaaaatgcttatgtctctgtagtgtcttcacattatagcaga agattcaccccagaaatagccaaaagacccaaagtaagagatcaggaaggaagaatcaactactactggactctgcngga acctggggatacaataatatttgaggcaaatggaaatctaatagcgccatggtatgcttttgcactgagtagaggctttg Type A Flu - HA1 gatcaggaatcatcacctcaaatgcaccaatggatgaatgtgatgcgaagtgtcaaacacctcagggagctataaacagc Positive agtcttcctttccagaatgtacacccagtcacaataggagagtgtccaaagtatgtcaggagtgcaaaatnaaggatggn tacaggactaaggaacatcccntccattcaatccagaggtttgtttggagccattgccggtttcattgaagnnnngtgga ctggaatggtagatgggtggtatggttatcatcatcagaatgagcaaggatcnggnnnnnnnncagatcaaaaaagtnca caaaatgccattaacgggattacaaacaaggtgannnnnnnnnnnnagaaaatgaacactcaattcacngcngtgggcaa agaattcaacaaattggaaagaaggatggaaaacttaaataaaaaagttgatgatgggtttctagacatttggannnnnn nnncagaattgttggttctacTGGAAAATGAAAGGACTTTGGATTTCCATGACTCCAATGTGAAGAatctgtatgagaaa gtaaaaagccaattaaagaataatgccaaagaaataggaaacgggtgttttgaattctatcacaagtgtaacaatgaatg catggagagtgtgaaaaatggaacttatgactatccaaaatattccgaagaatcaaagttaaacagggagaaaattgatg gagtgaaattggaatcaatgggagtctatcagattc >FLUAHA10:NRL_KB_FluVaccine_082206 Start=12 End=787 nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnngnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnngnnnnncnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnnnnnnntnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn Type A Flu - HA10 nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnnnnnnnnnnnnnnnnnannnnnnnncnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnncnnnnnnnnnnnnn Negative nnnnnnnnnnnngnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nnnnnnncaggaangagnannnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn nggnnnnnntnnnangnaggnnggnngnnnnnnnnnnnnnnnnnnncnnnnnnnnn… TessArae, LLC, Proprietary Information
  • 11. How to Identify a Novel Pathogen? TessArae, LLC, Proprietary Information
  • 12. RPM Detection of Novel Strains Old Strain New Strain TGGTAGTTGGGAAAATTAGCTTGAT Forward TGGTAGTTGGGAAAATTAGCTTGAT TGGTAGTTGGGACAATTAGCTTGAT strand TGGTAGTTGGGACAATTAGCTTGAT sequence TGGTAGTTGGGAGAATTAGCTTGAT TGGTAGTTGGGAGAATTAGCTTGAT variant TGGTAGTTGGGATAATTAGCTTGAT detection TGGTAGTTGGGATAATTAGCTTGAT CATACCATCAACCCTATTAATCGAACTACAGC target CATACCATCAACCCTGTTAATCGAACTACAGC GTATGGTAGTTGGGATAATTAGCTTGATGTCG GTATGGTAGTTGGGACAATTAGCTTGATGTCG ACCATCAACCCTATTAATCGAACTA Reverse ACCATCAACCCTATTAATCGAACTA ACCATCAACCCTCTTAATCGAACTA strand ACCATCAACCCTCTTAATCGAACTA ACCATCAACCCTGTTAATCGAACTA sequence ACCATCAACCCTGTTAATCGAACTA ACCATCAACCCTTTTAATCGAACTA variant ACCATCAACCCTTTTAATCGAACTA detection TessArae, LLC, Proprietary Information
  • 13. Detection of Novel Strains TessArae, LLC, Proprietary Information
  • 14. Novel H1N1 Influenza Detection TessArae, LLC, Proprietary Information
  • 15. Detecting Seasonal Strains of Influenza RPM-Detector Tiles for Seasonal A/H1N1 and Seasonal A/H3N2 Influenza Viruse s Vir u s Target Gen e Detector Tile Sequence/Strai n Leng t h Prob e s A/H1 N 1 Hemagglutinin(A/HA1 ) A/New Caledonia/20/1999(H1N1) 1500 bp 12,000 A/H1 N 1 Neuraminidase(A/N A 1 ) A/New Caledonia/20/1999(H1N1) 1200 bp 9,600 A/H1 N 1 Matrix(A/H1N1-M ) A/Canterbury/100/2000(H1N1) 850 bp 6,800 A/H3 N 2 Hemagglutinin(A/HA3 ) A/Canterbury /125/2005(H3 N 2 ) 1500 bp 12,000 A/H3 N 2 Neuraminidase(A/N A 2 ) A/Canterbury /125/2005(H3 N 2 ) 1200 bp 9,600 A/H3 N 2 Matrix(A/H3N2-M ) A/Canterbury /125/2005(H3 N 2 ) 850 bp 6,800 TessArae, LLC, Proprietary Information
  • 16. A Sentinel Case April 2009:  Patient presents at Washington, DC hospital  Recently returned from vacation in Mexico  Convalescing from recent flu-like illness  Anxious about reports of novel influenza outbreak TessArray Outcomes: 01 May 2009 - Best Matches L20309, X90504 H influenzae outer membrane protein P5 A/duck/Guanxi/2004(H5N1); A/chicken/Yogjakarta/2004(H5N1) Very unusual result suggested patient had been infected by an avian influenza virus Database updated following week, new sequence records from Mexico outbreak isolates 05 May 2009 - Best Matches L20309, X90504 H influenzae outer membrane protein P5 A/California/07/2009(H1N1); A/Texas/04/2009(H1N1) Perfect Match to New CDC Strain! From a Test Designed in 2006 With No Prior Knowledge of New Strain TessArae, LLC, Proprietary Information
  • 17. T S R A - A ML_CNMC_01_050109 (“RPM-Flu Sentinel Case”) Best Matches from VSRD Archive Best Matches from VSRD Archive Updated November 2008 Updated May 2009 A/chicken/Indonesia/7/2003(H5N1) A/chicken/Puebla/231-5284/98(H5N2) A/chicken/Puebla/231-5284/98 (H5N2) A/chicken/Yogjakarta/BBVet-IX/2004(H5N1) A/duck/Guangxi/1436/2006(H5N1) A/duck/Guangxi/351/2004(H5N1) A/duck/Guangxi/3548/2005(H5N1) A/duck/Guangxi/380/2004(H5N1) A/duck/Guangxi/4016/2005(H5N1) A/hooded vulture/Burkina Faso/2/2006(H5N1) A/mallard/Alberta/111/99(H4N6) A/mallard/Alberta/111/99(H4N6) A/mallard/Maryland/1235/2006(H3N6) A/mallard/Maryland/1235/2006(H3N6) A/quail/Tasikmalaya/BPPV4/2004(H5N1) A/swine/Hong Kong/1197/02(H3N2) A/swine/Hong Kong/1197/02(H3N2) A/swine/Iowa/930/01(H1N2) A/swine/Virginia/670/1987(H1N1) A/swine/Virginia/671/1987(H1N1) A/swine/British Columbia/28103/2005(H3N2) A/California/04/2009(H1N1) A/California/05/2009(H1N1) A/California/06/2009(H1N1) A/California/07/2009(H1N1) RPM detection and identification works for A/California/08/2009(H1N1) A/California/09/2009(H1N1) A/California/10/2009(H1N1) strains and variants A/California/14/2009(H1N1) A/Canada-ON/RV1527/2009(H1N1) that share at least 80% sequence similarity to A/New York/06/2009(H1N1) A/New York/10/2009(H1N1) array detector tiles A/New York/11/2009(H1N1) A/New York/15/2009(H1N1) A/New York/18/2009(H1N1) A/New York/19/2009(H1N1) A/New York/20/2009(H1N1) A/New York/22/2009(H1N1) A/Ohio/07/2009(H1N1) A/Texas/04/2009(H1N1) A/Texas/05/2009(H1N1) 190/215 = 88% The RPM-Flu 3.1 designed for A/H5N1 in 2006 is capable to sensitively detect and differentiate the Novel A/H1N1 SOIV from Seasonal A/H1N1 and Seasonal A/H3N2 subtypes without modification TessArae, LLC, Proprietary Information
  • 18. Avian A/H5N1 matrix gene resequencing detector tile sequence (top sequence) 2009 Novel H1N1 (A/Pensacola/INS107/200 9(H1N1)) strain (middle sequence) Sequence from a high titer stock of a 2009 Novel H1N1 outbreak strain strain, A/NHRC- California/BRD_40116(H1N1) (bottom sequence) Legend: “x” = Mismatch “|” = Match TessArae, LLC, Proprietary Information
  • 19. Analytical Sensitivity with Cultured Influenza Virus Seasonal H1N1 Seasonal H3N2 Novel H1N1 LoD (95%) TCID50/ml TessArray RPM-Flu CDC rRT-PCR (JBAIDS)  Novel A/H1N1 1,740  Novel A/H1N1 5,000  Seasonal A/H1N1 102  Seasonal A/H1N1 10  Seasonal A/H3N2 224  Seasonal A/H3N2 100 TessArae, LLC, Proprietary Information
  • 20. Analytical Sensitivity Cultured Influenza Virus Seasonal Seasonal 2009 Novel Controls A/H1N1 A/H3N2 A/H1N1 SOIV Endpoint LoD Titration Seasonal A/H1N1 38/38 (100%) 0/41 (0%) 0/41 (0%) Seasonal A/H3N2 0/58 (0%) 44/44 (100%) 0/58 (0%) 2009 Novel A/H1N1(SOIV) 0/55 (0%) 0/55 (0%) 44/44 (100%) Positive Clinical Specimens Seasonal A/H1N1 13/13 (100%) 0/13 (0%) 0/13 (0%) Seasonal A/H3N2 0/31 (0%) 31/31 (100%) 0/31 (0%) 2009 Novel A/H1N1(SOIV) 0/8 (0%) 0/8 (0%) 8/8 (100%) Negative Controls Avian A/H5N1-positive 0/16 (0%) 0/16 (0%) 0/16 (0%) Other High Load Pathogens 0/24 (0%) 0/24 (0%) 0/24 (0%) Water Blanks 0/14 (0%) 0/14 (0%) 0/14 (0%) Clinical Negative by PCR 0/501 (0%) 0/501 (0%) 0/501 (0%) TessArae, LLC, Proprietary Information
  • 21. Detecting Emergent Strains What’s on the Device: 2004-5 FluMist A/New Caledonia/20/1999(H1N1) Hemagglutinin A/New Caledonia/20/1999(H1N1) A/New Caledonia/20/1999(H1N1) Neuraminidase A/New Caledonia/20/1999(H1N1) A/Canterbury/100/2000(H1N1) Matrix A/Ann Arbor/6/1960(H2N2) A/Canterbury/125/2005 (H3N2) Hemagglutinin A/Wyoming/03/2003 (H3N2) A/Canterbury/125/2005 (H3N2) Neuraminidase A/Wyoming/03/2003 (H3N2) A/Canterbury/125/2005 (H3N2) Matrix A/Ann Arbor/6/1960(H2N2) What it Told Us: 2009-10 FluMist A/South Dakota/6/2007(H1N1) A/South Dakota/6/2007(H1N1) A/Ann Arbor/6/1960(H2N2) A/Uruguay/716/2007 (H3N2) TessArae, LLC A/Uruguay/716/2007 (H3N2) TessArray RPM-Flu v3.1 Respiratory Pathogen Panel A/Ann Arbor/6/1960(H2N2) P/N: 520-191 2006-7 FluZone A/New Caledonia/20/1999(H1N1) A/New Caledonia/20/1999(H1N1) A/Puerto Rico/8/1934(H1N1) A/Wisconsin/67/2005 (H3N2) TessArray™ A/Wisconsin/67/2005 (H3N2) A/Puerto Rico/8/1934(H1N1) 2009-10 FluVirin When Confronted With Different A/South Dakota/6/2007(H1N1) Strains the Array Still Tells Us A/South Dakota/6/2007(H1N1) A/Puerto Rico/8/1934(H1N1) What Is Present Based on the A/Uruguay/716/2007 (H3N2) A/Uruguay/716/2007 (H3N2) Sequences of the Organisms A/Puerto Rico/8/1934(H1N1) TessArae, LLC, Proprietary Information
  • 22. Avian Influenza Subtypes: Differential Diagnostics Specimens from USDA ARS SEPRL reference archive (20 Mar 08) Sample RPM Assay Match SEPRL Reference Strain 1 H1N1 H1N1 A/Turkey/Kansas/4880/80 2 H2N8 H2N8 A/Herring Gull/DE/677/88 3 H3N2 H3N2 A/turkey/MN/366767/2005 4 H4N6 H4N6 A/Blue Winged Teal/LA/240B/88 6 H7N2 H7N2 A/quail/PA/20304/98 7 H8N4 H8N4 A/turkey/CO/169118-13/02 9 H10N7 H10N7 A/quail/NJ/25254-22/95 10 H11N3 H11N3 A/chicken/NJ/4645/96 11 H12N5 H12N5 A/duck/LA/188D/87 12 H13N6 H13N6 A/gull/MD/1824/78 13 AMPV, No AI AMPV, No AI Avian Metapneumovirus (Colorado Strain) 14 H5N3 H5N3 A/duck/Singapore/F119/97 15 H7N3 H7N3 A/chicken/Chile(F0)/176822/02 16 No AI No AI Avian Paramyxovirus I (NDV, RPM-TEI assay) 17 H5N2 H5N2 A/chicken/Mex/26654-1374/94 18 H7N1 H7N1 A/turkey/Italy/4580/99 19 H7N3 H7N3 A/chicken/Pakistan/1369-CR2/95 20 H7N7 H7N7 A/chicken/Victoria/85 21 H14N5 H14N5 A/mallard/Gurjev/263/82 22 H15N9 H15N9 A/Shearwater/W. Australia/2576/79 TessArae, LLC, Proprietary Information
  • 23. Avian Influenza Subtypes: Differential Diagnostics Reconciliation of Inter-Platform Results Discrepancies by de novo DNA Sequencing of Viral Genes from Original Specimens CDC-Certified Ibis-T5000 HA RSLT (P1) TessArray® Gold Standard Sample ID H5 (Asian) PCR ESI-MS RPM-Flu v3.1 DNA Sequencing 2006900845 H5 H5N1 H5 H5N1 not tested 2006906089 H5 H5N1 H5 H5N1 not tested 2006900590 H5 H5N1 H5 H5N1 not tested 2006902838 H5 H5N1 H5 H5N1 not tested 2006902764 not tested H5N1 H5 H5N1 H5N1 2006905588 Flu UNKNOWN H7 H7N7 H7N7 2004909864 not tested H9N2 UNKNOWN H7N7 H7 2005912823 Flu H7N7 UNKNOWN H10N7 H10N7 2005912908 not tested H7N7 H10 H10N7 H10N7 2004900600 Flu H7N7 H10 H10N7 H10N7 2004900845 H5 H5N1 H10 H10N7 or H10N5 H10N7 2004900688 not tested H7N7 H11 H11N? H11 2005912306 Flu NEW UNKNOWN H13N6 or H13N8 H13 Lin et al PLOS 2009 = Conflict with de novo sequencing results = Results concordant with de novo sequencing TessArae, LLC, Proprietary Information
  • 24. Longitudinal Data Analysis CT_Healthy_Control_080508 CT_Sick_Day4_080603 Metapneumovirus CT_Sick_050509 Rhinovirus But not the novel A/H1N1! CT_Sick_042010 Parainfluenza Virus TessArae, LLC, Proprietary Information
  • 25. MLST-like Epidemiological Analysis: Genomic diversity of Haemophilus influenzae from 50 Different Patients at MCRD San Diego TessArae, LLC, Proprietary Information
  • 26. MLST-Like Epidemiological Analysis: Clonal genomic uniformity of Adenovirus Type 4 in Same 50 Patients at MCRD San Diego TessArae, LLC, Proprietary Information
  • 27. Summary  Real-time Epidemic/Pandemic Surveillance in Human and Animal Populations  Simultaneous Detection and Definitive Identification of Multiple Pathogens  Characterization of Difficult Cases  Superior to Benchmark Platform Sensitivity and Specificity  Limits of Detection ~ 102 Genome Equivalents/specimen  Zero False Positive Detection Events  Immediate Identification of Known and Unknown Strains and Variants  Surveillance of Shift and Drift in Populations  Same Day Results  RPM Sequence-based Detector Array  Six Sigma Data Quality  Basecall Error Rate ≥ 10-6 TessArae, LLC, Proprietary Information
  • 28. Acknowledgements TessArae, LLC - Potomac Falls, VA Clark Tibbetts Brian Weslowski Leah Morris Matthew Lorence Lisa Borsuk Klaus Schafer Naval Health Research Center/Naval Respiratory Disease Laboratory, San Diego, CA David Metzgar Chris Myers Christian Hansen CDR Kevin Russell Jason Brown Larivhie Dela Cruz CDR Dennis Faix Miguel Osuna David Ortiz Naval Research Laboratory/Center for Bio/Molecular Science and Engineering - Washington, DC Joel Schnur Anthony Malanoski Nina Long David Stenger Baochuan Lin Carolyn Kidd Zheng Wang Dzung Thach Kate Blaney TessArae, LLC, Proprietary Information